EXACT Sciences Net Income
| EXAS Stock | USD 103.25 0.02 0.02% |
As of the 27th of February, EXACT Sciences owns the Market Risk Adjusted Performance of 1.48, standard deviation of 0.1676, and Coefficient Of Variation of 435.49. EXACT Sciences technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EXACT Sciences standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if EXACT Sciences is priced correctly, providing market reflects its prevailing price of 103.25 per share. Given that EXACT Sciences has treynor ratio of 1.47, we urge you to verify EXACT Sciences's latest market performance to make sure the company can sustain itself in the future.
EXACT Sciences Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.5498 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -207.9 M | -218.3 M | |
| Net Loss | -207.9 M | -218.3 M | |
| Net Loss | -561.2 M | -533.1 M | |
| Net Loss | (1.10) | (1.16) | |
| Net Income Per E B T | 1.02 | 0.67 |
EXACT | Net Income | Build AI portfolio with EXACT Stock |
The evolution of Net Income for EXACT Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how EXACT Sciences compares to historical norms and industry peers.
Latest EXACT Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of EXACT Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in EXACT Sciences financial statement analysis. It represents the amount of money remaining after all of EXACT Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is EXACT Sciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (207.95 M) | 10 Years Trend |
|
Net Income |
| Timeline |
EXACT Net Income Regression Statistics
| Arithmetic Mean | (280,054,321) | |
| Coefficient Of Variation | (107.03) | |
| Mean Deviation | 229,573,614 | |
| Median | (175,149,000) | |
| Standard Deviation | 299,736,036 | |
| Sample Variance | 89841.7T | |
| Range | 1B | |
| R-Value | (0.60) | |
| Mean Square Error | 61766.7T | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | (35,388,813) | |
| Total Sum of Squares | 1437467.1T |
EXACT Net Income History
Other Fundumenentals of EXACT Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
EXACT Sciences Net Income component correlations
EXACT Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for EXACT Sciences is extremely important. It helps to project a fair market value of EXACT Stock properly, considering its historical fundamentals such as Net Income. Since EXACT Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EXACT Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EXACT Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will EXACT introduce new products? Factors like these will boost the valuation of EXACT Sciences. Projected growth potential of EXACT fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share | Quarterly Revenue Growth 0.231 | Return On Assets | Return On Equity |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between EXACT Sciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EXACT Sciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, EXACT Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
EXACT Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EXACT Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EXACT Sciences.
| 11/29/2025 |
| 02/27/2026 |
If you would invest 0.00 in EXACT Sciences on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding EXACT Sciences or generate 0.0% return on investment in EXACT Sciences over 90 days. EXACT Sciences is related to or competes with Guardant Health, ICON PLC, Viatris, BridgeBio Pharma, Summit Therapeutics, Revvity, and Roivant Sciences. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and international... More
EXACT Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EXACT Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EXACT Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1489 | |||
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 0.7677 | |||
| Value At Risk | (0.23) | |||
| Potential Upside | 0.3544 |
EXACT Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for EXACT Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EXACT Sciences' standard deviation. In reality, there are many statistical measures that can use EXACT Sciences historical prices to predict the future EXACT Sciences' volatility.| Risk Adjusted Performance | 0.1401 | |||
| Jensen Alpha | 0.0269 | |||
| Total Risk Alpha | 0.011 | |||
| Sortino Ratio | (0.35) | |||
| Treynor Ratio | 1.47 |
EXACT Sciences February 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1401 | |||
| Market Risk Adjusted Performance | 1.48 | |||
| Mean Deviation | 0.1269 | |||
| Downside Deviation | 0.1489 | |||
| Coefficient Of Variation | 435.49 | |||
| Standard Deviation | 0.1676 | |||
| Variance | 0.0281 | |||
| Information Ratio | (0.31) | |||
| Jensen Alpha | 0.0269 | |||
| Total Risk Alpha | 0.011 | |||
| Sortino Ratio | (0.35) | |||
| Treynor Ratio | 1.47 | |||
| Maximum Drawdown | 0.7677 | |||
| Value At Risk | (0.23) | |||
| Potential Upside | 0.3544 | |||
| Downside Variance | 0.0222 | |||
| Semi Variance | (0.02) | |||
| Expected Short fall | (0.14) | |||
| Skewness | 0.5052 | |||
| Kurtosis | 0.4084 |
EXACT Sciences Backtested Returns
Currently, EXACT Sciences is very steady. EXACT Sciences retains Efficiency (Sharpe Ratio) of 0.21, which denotes the company had a 0.21 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for EXACT Sciences, which you can use to evaluate the volatility of the firm. Please confirm EXACT Sciences' Standard Deviation of 0.1676, coefficient of variation of 435.49, and Market Risk Adjusted Performance of 1.48 to check if the risk estimate we provide is consistent with the expected return of 0.0351%. EXACT Sciences has a performance score of 16 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.0194, which means not very significant fluctuations relative to the market. As returns on the market increase, EXACT Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding EXACT Sciences is expected to be smaller as well. EXACT Sciences now owns a risk of 0.17%. Please confirm EXACT Sciences standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if EXACT Sciences will be following its current price history.
Auto-correlation | 0.63 |
Good predictability
EXACT Sciences has good predictability. Overlapping area represents the amount of predictability between EXACT Sciences time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EXACT Sciences price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current EXACT Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
EXACT Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, EXACT Sciences reported net income of (207.95 Million). This is 160.93% lower than that of the Biotechnology sector and 220.12% lower than that of the Health Care industry. The net income for all United States stocks is 136.42% higher than that of the company.
EXACT Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXACT Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics of similar companies.EXACT Sciences is currently under evaluation in net income category among its peers.
EXACT Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EXACT Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EXACT Sciences' managers, analysts, and investors.Environmental | Governance | Social |
EXACT Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in EXACT Sciences that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of EXACT Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EXACT Sciences' value.| Shares | Ameriprise Financial Inc | 2025-06-30 | 2.2 M | Goldman Sachs Group Inc | 2025-06-30 | 2.2 M | Millennium Management Llc | 2025-06-30 | 2.2 M | Holocene Advisors, Lp | 2025-06-30 | 2.1 M | William Blair Investment Management, Llc | 2025-06-30 | 2 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.9 M | Bamco Inc | 2025-06-30 | 1.9 M | Aqr Capital Management Llc | 2025-06-30 | 1.8 M | Fmr Inc | 2025-06-30 | 26.9 M | Capital World Investors | 2025-06-30 | 18.2 M |
EXACT Fundamentals
| Return On Equity | -0.0866 | ||||
| Return On Asset | -0.0159 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 21.27 B | ||||
| Shares Outstanding | 190.89 M | ||||
| Shares Owned By Insiders | 1.30 % | ||||
| Shares Owned By Institutions | 86.59 % | ||||
| Number Of Shares Shorted | 7.12 M | ||||
| Price To Earning | (38.17) X | ||||
| Price To Book | 8.21 X | ||||
| Price To Sales | 6.08 X | ||||
| Revenue | 3.25 B | ||||
| Gross Profit | 2.26 B | ||||
| EBITDA | 122.5 M | ||||
| Net Income | (207.95 M) | ||||
| Cash And Equivalents | 728.04 M | ||||
| Cash Per Share | 4.11 X | ||||
| Total Debt | 2.52 B | ||||
| Debt To Equity | 0.77 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | 12.58 X | ||||
| Cash Flow From Operations | 491.44 M | ||||
| Short Ratio | 2.99 X | ||||
| Earnings Per Share | (1.10) X | ||||
| Price To Earnings To Growth | (1.07) X | ||||
| Target Price | 105.81 | ||||
| Number Of Employees | 7.1 K | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 19.73 B | ||||
| Total Asset | 5.86 B | ||||
| Retained Earnings | (4.71 B) | ||||
| Working Capital | 914.7 M | ||||
| Current Asset | 325.86 M | ||||
| Current Liabilities | 26.72 M | ||||
| Net Asset | 5.86 B |
About EXACT Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXACT Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.